UT MD Anderson

Running trials

• Not yet recruiting

  A Phase 1a/1b Of Zanidatamab In Combination With Zongertinib In HER2-Mutated Non-Small Cell Lung Cancer (NSCLC)

  NCT07899801· Phase 1· Source

• Not yet recruiting

  Estimating The Rate Of Complete Ablation (A0) With The Use Of Biomechanical Deformable Image Registration

  NCT07877220· Source

• Not yet recruiting

  2 Gy Total Body Irradiation As Part Of Conditioning Treatment For Patients With Acute Lymphoblastic Leukemia Undergoing CAR T Cell Therapy

  NCT07856758· Source

• Not yet recruiting

  Phase 1/2 Study Of PARP Inhibition With Olaparib To Enhance The Efficacy Of High-Dose Chemotherapy In Refractory And Relapsed Germ Cell Tumors

  NCT07850973· Phase 1/2· Source

• Not yet recruiting

  Proactively Intervening On Early Cranial Nerve Injury As A Delayed Sequela Of Oropharyngeal Cancer: A Randomized Feasibility Clinical Trial For Pro-Habilitation (proNERVE RCT)

  NCT07832266· Phase 1· Source

• Not yet recruiting

  Understanding the Role of MyCareGorithm as a Visual Digital Platforms in Cancer Treatment Education and Patient Comprehension of Oncology Treatment Plans

  NCT07852949· Source

• Not yet recruiting

  A Ph2, Colchicine For Inflammatory Carotid Injury And Disease Evolution After Radiotherapy

  NCT07856719· Phase 2· Source

• Not yet recruiting

  Dissemination Of Lung Cancer Screening Education Through Tobacco Quitlines

  NCT07720141· Source

• Not yet recruiting

  Development Of An Endometrial Cancer Educational Tool

  NCT07739745· Source

• Not yet recruiting

  A Phase 2 Trial Of The Combination Of Zanubrutinib, Sonrotoclax, And Obinutuzumab For Patients With Treatment-Naïve Chronic Lymphocytic Leukemia

  NCT07674810· Phase 2· Source

• Not yet recruiting

  Study Of KITE-753 in R/R B-Cell ALL

  NCT07674823· Phase 1· Source

• Not yet recruiting

  Phase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AML

  NCT07604233· Phase 1/2· Source

• Recruiting

  PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In Adolescent And Young Adult Cancer Survivors - A Phase 2 Single-Arm, Single-Center Feasibility Study

  NCT07874828· Phase 2· Source

• Not yet recruiting

  Phase I Study Of PLM-102 In Patients With Relapsed And Refractory Acute Myeloid Leukemia

  NCT07549464· Phase 1· Source

• Recruiting

  A Phase 2 Study Of Zanzalintinib For Patients With Recurrent Or Metastatic Olfactory Neuroblastoma

  NCT07527169· Phase 2· Source

• Not yet recruiting

  A Phase 1 Trial Of Safety And Initial Efficacy Of Vagal Nerve Blockade For Cancer-Induced Cachexia In Patients With Metastatic Pancreatic Adenocarcinoma

  NCT07700212· Phase 1· Source

• Not yet recruiting

  RISE: Reducing Cancer and HIV Stigma Through Empowerment

  NCT07728370· Source

• Recruiting

  A Phase 2 Trial Of The Bruton Tyrosine Kinase Degrader BGB-16673 In Combination With BCL-2 Inhibitor Sonrotoclax For Patients With Treatment-Naive Chronic Lymphocytic Leukemia (CLL)

  NCT07508995· Phase 2· Source

• Recruiting

  Phase II Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL

  NCT07551583· Phase 2· Source

• Recruiting

  Phase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum

  NCT07509008· Phase 1/2· Source

• Recruiting

  Ph1/2 Trial Of Navlimetostat With Pumitamig In MTAP-Deficient Advanced Non-Small Cell Lung Cancer

  NCT07579221· Phase 1/2· Source

• Recruiting

  Phase 2 Study Of Mosunetuzumab In Patients With Chronic Lymphocytic Leukemia With Positive MRD

  NCT07566364· Phase 2· Source

• Recruiting

  Phase 1 Study Of LNK001 In Advanced Or Metastatic Clear Cell Renal Cell Carcinoma

  NCT07564232· Phase 1· Source

• Recruiting

  Venetoclax, Dexamethasone, Bortezomib, and Daratumumab For The Treatment Of Adolescent And Young Adults With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And T-cell Acute Lymphoblastic Lymphoma

  NCT07513129· Phase 1· Source

• Not yet recruiting

  Barriers And Facilitators To Clinical Trial Enrollment: A Qualitative Study Of Pancreatic Cancer Patients

  NCT07591480· Source

• Recruiting

  A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

  NCT06440005· Phase 1· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute lymphoblastic leukaemia3 recruiting
• Childhood cancers3 recruiting
• Chronic lymphocytic leukaemia3 recruiting
• Head and neck cancer3 recruiting
• Lung cancer3 recruiting
• Pancreatic cancer3 recruiting
• Acute myeloid leukemia2 recruiting
• Liver and biliary tract cancer2 recruiting
• Prostate cancer2 recruiting
• Sarcoma2 recruiting
• Cervical cancer1 recruiting
• Chronic myeloid leukaemia1 recruiting
• Colorectal cancer1 recruiting
• Endometrial cancer1 recruiting
• Gastric and esophageal cancer1 recruiting
• HIV1 recruiting
• Hodgkin lymphoma1 recruiting
• Kidney cancer1 recruiting
• Neuroblastoma1 recruiting
• Obesity1 recruiting

Researchers

No researcher is linked here yet.